EmployblEmploybl logo
employbl
Alector logo

Alector Funding & Investors

Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California.

alector.com

Total Amount Raised: $194,500,000

Alector Funding Rounds

  • Series E

    $133,000,000

    Series E Investors

    GV
    New Leaf Venture Partners
    Dementia Discovery Fund
    Foresite Capital
    MRL Ventures Fund
    AbbVie Biotech Ventures
    Perceptive Advisors
    Lilly Asia Ventures
    Federated Kaufmann Fund
    Casdin Capital
    Amgen
    Deerfield Capital Management
    Section 32
    Polaris Partners
    Euclidean Capital
    Mission Bay Capital
    OrbiMed
    Mission BioCapital

  • Series D

    $29,500,000

    Series D Investors

    Dementia Discovery Fund
    Polaris Partners
    OrbiMed
    MRL Ventures Fund
    Topspin Partners
    AbbVie Biotech Ventures
    Amgen
    GV
    Mission Bay Capital

  • Series C

    $32,000,000

    Series C Investors

    MRL Ventures Fund
    OrbiMed
    Polaris Partners
    GV
    Topspin Partners
    Mission Bay Capital
Funding info provided by Diffbot.